EPO and anemia (phenotype): Erythropoietin-stimulating agents, one of the treatment options for anaemia, raise haemoglobin levels, reduce the proportion of patients requiring transfusions and improve QOL (Littlewood et al, 2001; Österborg et al, 2002; Boogaerts et al, 2003; Iconomou et al, 2003).